Have any questions?
get in touchTel : (86) 592-680-7188
E-mail : intecproducts@asintec.com
WHO Pre-qualified
CE-Marked
Sensitivity: 100%
Specificity: 100%
Ultra Sensitive
INTENDED USE
The AQ+ COVID-19 Ag Rapid Test is a colloidal gold enhanced, rapid immunochromatographic assay for qualitative detection of SARS-CoV-2 antigens in the nasopharyngeal/ nasal specimen collected by swabs from individuals who are suspected of having COVID-19. The test is used as an aid in the diagnosis of SARS-CoV-2 infection. The test is suitable for use under healthcare professional supervision. Individuals should have appropriate training in how to administer the test correctly. Remote healthcare professional supervision can be used with appropriate clinical governance, once training has been completed and verified.
﹒Sensitivity: 93.64%
﹒Specificity: 100.00%
﹒Specimen: Nasal specimen
﹒ISO13485
CE –marked
﹒BfArM Test-ID: AT981/21
﹒Specimen: Nasopharyngeal/nasal specimen
﹒Sensitivity(NP): 96.3%
﹒Specificity(NP): 100%
﹒Sensitivity(N): 95.5%
﹒Specificity(N): 99.6%
INTENDED USE
The kit is intended to qualitatively detect Toxoplasma IgM, Toxoplasma IgG, Cytomegaloviru IgM, Cytomegaloviru IgG and Rubella virus IgG in human serum, plasma or whole blood in vitro. It is suitable for clinical auxiliary diagnosis of Toxoplasma infection, Cytomegalovirus infection and Rubella virus infection as well as their epidemiological inverstigation.
CE-marked
Sensitivity: 93.10%
Specificity: 100%
Specimen type: nasopharyngeal swabs
CE-marked
Sensitivity:
The Rapid Troponin l Test can detect cTnl in whole blood, serum or plasma with concentration of 0.5ng/ml or greater.
CE-marked
Specimen: whole blood, serum or plasma